TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/8/21 16:16 | 12/6/21 | APTX | Aptinyx Inc. | DE | Health | Drug | Pharmaceutical Preparations | Riedel Norbert G | IL | DO | CEO | P | 223 | 2.23 | 0 | 100 | 8 | 1,356 | I | ||||||||||||||
1/14/20 16:23 | 1/10/20 | APTX | Aptinyx Inc. | DE | Health | Drug | Pharmaceutical Preparations | Riedel Norbert G | IL | DO | CEO,P | P | 105 | 3.00 | 0 | 35 | 4 | 1,003 | I | ||||||||||||||
11/15/18 19:10 | 11/15/18 | ETON | Eton Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Riedel Norbert G | IL | D | P | 30 | 6.00 | 0 | 5 | 9 | 60 | D | |||||||||||||||
6/26/18 16:44 | 6/25/18 | APTX | Aptinyx Inc. | DE | Health | Drug | Pharmaceutical Preparations | Riedel Norbert G | IL | DO | CEO,P | P.d | 38 | 16.00 | 0 | 2 | 0 | 930 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |